Cite Filings / LBRX / 0001193125-25-209153

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

LB PHARMACEUTICALS INC Filed 2025-09-19 Acc 0001193125-25-209153

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-09-25 SCHEDULE 13D Beneficial Ownership Report
2025-09-19 SCHEDULE 13G Statement of Beneficial Ownership
2025-09-19 SCHEDULE 13D Beneficial Ownership Report
2025-09-18 SCHEDULE 13G Statement of Beneficial Ownership
2025-09-18 SCHEDULE 13G Statement of Beneficial Ownership
2025-09-16 3 Initial Statement of Ownership
2025-09-16 4 10% owner bought 1,000,000 shares at $15.00 ($15,000,000)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…